A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT00929903

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:35:37.262614+00:00

Published At

2013-09-30T00:00:00+00:00

Record Updated At

2013-09-30

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Childhood Central Nervous System Choriocarcinoma", "Childhood Central Nervous System Embryonal Tumor", "Childhood Central Nervous System Germ Cell Tumor", "Childhood Central Nervous System Germinoma", "Childhood Central Nervous System Mixed Germ Cell Tumor", "Childhood Central Nervous System Teratoma", "Childhood Central Nervous System Yolk Sac Tumor", "Metastatic Childhood Soft Tissue Sarcoma", "Recurrent Childhood Brain Stem Glioma", "Recurrent Childhood Central Nervous System Embryonal Tumor", "Recurrent Childhood Soft Tissue Sarcoma", "Recurrent Childhood Visual Pathway Glioma", "Unspecified Childhood Solid Tumor, Protocol Specific"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2013-09-30"

protocolSection.identificationModule.nctId

"NCT00929903"

protocolSection.identificationModule.officialTitle

"A Phase I Study of Pazopanib as a Single Agent for Children With Relapsed or Refractory Solid Tumors"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE1"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Childhood Central Nervous System Choriocarcinoma (protocolSection.conditionsModule.conditions)
• Childhood Central Nervous System Embryonal Tumor (protocolSection.conditionsModule.conditions)
• Childhood Central Nervous System Germ Cell Tumor (protocolSection.conditionsModule.conditions)
• Childhood Central Nervous System Germinoma (protocolSection.conditionsModule.conditions)
• Childhood Central Nervous System Mixed Germ Cell Tumor (protocolSection.conditionsModule.conditions)
• Childhood Central Nervous System Teratoma (protocolSection.conditionsModule.conditions)
• Childhood Central Nervous System Yolk Sac Tumor (protocolSection.conditionsModule.conditions)
• Metastatic Childhood Soft Tissue Sarcoma (protocolSection.conditionsModule.conditions)
• Recurrent Childhood Brain Stem Glioma (protocolSection.conditionsModule.conditions)
• Recurrent Childhood Central Nervous System Embryonal Tumor (protocolSection.conditionsModule.conditions)
• Recurrent Childhood Soft Tissue Sarcoma (protocolSection.conditionsModule.conditions)
• Recurrent Childhood Visual Pathway Glioma (protocolSection.conditionsModule.conditions)
• Unspecified Childhood Solid Tumor, Protocol Specific (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.